Literature DB >> 26018413

Dynamic Proteome Response of Pseudomonas aeruginosa to Tobramycin Antibiotic Treatment.

Xia Wu1, Kiara Held1, Chunxiang Zheng2, Benjamin J Staudinger3, Juan D Chavez1, Chad R Weisbrod1, Jimmy K Eng1, Pradeep K Singh3, Colin Manoil1, James E Bruce4.   

Abstract

Genetically susceptible bacteria become antibiotic tolerant during chronic infections, and the mechanisms responsible are poorly understood. One factor that may contribute to differential sensitivity in vitro and in vivo is differences in the time-dependent tobramycin concentration profile experienced by the bacteria. Here, we examine the proteome response induced by subinhibitory concentrations of tobramycin in Pseudomonas aeruginosa cells grown under planktonic conditions. These efforts revealed increased levels of heat shock proteins and proteases were present at higher dosage treatments (0.5 and 1 μg/ml), while less dramatic at 0.1 μg/ml dosage. In contrast, many metabolic enzymes were significantly induced by lower dosages (0.1 and 0.5 μg/ml) but not at 1 μg/ml dosage. Time course proteome analysis further revealed that the increase of heat shock proteins and proteases was most rapid from 15 min to 60 min, and the increased levels sustained till 6 h (last time point tested). Heat shock protein IbpA exhibited the greatest induction by tobramycin, up to 90-fold. Nevertheless, deletion of ibpA did not enhance sensitivity to tobramycin. It seemed possible that the absence of sensitization could be due to redundant functioning of IbpA with other proteins that protect cells from tobramycin. Indeed, inactivation of two heat shock chaperones/proteases in addition to ibpA in double mutants (ibpA/clpB, ibpA/PA0779 and ibpA/hslV) did increase tobramycin sensitivity. Collectively, these results demonstrate the time- and concentration-dependent nature of the P. aeruginosa proteome response to tobramycin and that proteome modulation and protein redundancy are protective mechanisms to help bacteria resist antibiotic treatments.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26018413      PMCID: PMC4528242          DOI: 10.1074/mcp.M115.050161

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  49 in total

1.  ClpB and HtpG facilitate de novo protein folding in stressed Escherichia coli cells.

Authors:  J G Thomas; F Baneyx
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

2.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

3.  Small heat shock proteins, ClpB and the DnaK system form a functional triade in reversing protein aggregation.

Authors:  Axel Mogk; Elke Deuerling; Sonja Vorderwülbecke; Elizabeth Vierling; Bernd Bukau
Journal:  Mol Microbiol       Date:  2003-10       Impact factor: 3.501

4.  Functions required for extracellular quinolone signaling by Pseudomonas aeruginosa.

Authors:  Larry A Gallagher; Susan L McKnight; Marina S Kuznetsova; Everett C Pesci; Colin Manoil
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

5.  Cadaverine suppresses persistence to carboxypenicillins in Pseudomonas aeruginosa PAO1.

Authors:  Jerrylynn Manuel; George G Zhanel; Teresa de Kievit
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

6.  Gene expression in Pseudomonas aeruginosa biofilms.

Authors:  M Whiteley; M G Bangera; R E Bumgarner; M R Parsek; G M Teitzel; S Lory; E P Greenberg
Journal:  Nature       Date:  2001-10-25       Impact factor: 49.962

7.  PseudoCyc, a pathway-genome database for Pseudomonas aeruginosa.

Authors:  Pedro Romero; Peter Karp
Journal:  J Mol Microbiol Biotechnol       Date:  2003

Review 8.  Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.

Authors:  Susan M Cheer; John Waugh; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis.

Authors:  David E Geller; William H Pitlick; Pasqua A Nardella; William G Tracewell; Bonnie W Ramsey
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

10.  MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides.

Authors:  Didier Hocquet; Christelle Vogne; Farid El Garch; Anne Vejux; Naomasa Gotoh; Angela Lee; Olga Lomovskaya; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

View more
  13 in total

Review 1.  Cross-Linking Mass Spectrometry: An Emerging Technology for Interactomics and Structural Biology.

Authors:  Clinton Yu; Lan Huang
Journal:  Anal Chem       Date:  2017-11-21       Impact factor: 6.986

2.  Systems structural biology measurements by in vivo cross-linking with mass spectrometry.

Authors:  Juan D Chavez; Jared P Mohr; Martin Mathay; Xuefei Zhong; Andrew Keller; James E Bruce
Journal:  Nat Protoc       Date:  2019-07-03       Impact factor: 13.491

3.  In Vivo Proteome of Pseudomonas aeruginosa in Airways of Cystic Fibrosis Patients.

Authors:  Xia Wu; Richard J Siehnel; Jayanthi Garudathri; Benjamin J Staudinger; Katherine B Hisert; Egon A Ozer; Alan R Hauser; Jimmy K Eng; Colin Manoil; Pradeep K Singh; James E Bruce
Journal:  J Proteome Res       Date:  2019-05-22       Impact factor: 4.466

Review 4.  The Role of ClpB in Bacterial Stress Responses and Virulence.

Authors:  Athar Alam; Jeanette E Bröms; Rajender Kumar; Anders Sjöstedt
Journal:  Front Mol Biosci       Date:  2021-04-22

5.  In vivo protein interaction network analysis reveals porin-localized antibiotic inactivation in Acinetobacter baumannii strain AB5075.

Authors:  Xia Wu; Juan D Chavez; Devin K Schweppe; Chunxiang Zheng; Chad R Weisbrod; Jimmy K Eng; Ananya Murali; Samuel A Lee; Elizabeth Ramage; Larry A Gallagher; Hemantha D Kulasekara; Mauna E Edrozo; Cassandra N Kamischke; Mitchell J Brittnacher; Samuel I Miller; Pradeep K Singh; Colin Manoil; James E Bruce
Journal:  Nat Commun       Date:  2016-11-11       Impact factor: 14.919

6.  A General Method for Targeted Quantitative Cross-Linking Mass Spectrometry.

Authors:  Juan D Chavez; Jimmy K Eng; Devin K Schweppe; Michelle Cilia; Keith Rivera; Xuefei Zhong; Xia Wu; Terrence Allen; Moshe Khurgel; Akhilesh Kumar; Athanasios Lampropoulos; Mårten Larsson; Shuvadeep Maity; Yaroslav Morozov; Wimal Pathmasiri; Mathew Perez-Neut; Coriness Pineyro-Ruiz; Elizabeth Polina; Stephanie Post; Mark Rider; Dorota Tokmina-Roszyk; Katherine Tyson; Debora Vieira Parrine Sant'Ana; James E Bruce
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

7.  Extracellular DNA release, quorum sensing, and PrrF1/F2 small RNAs are key players in Pseudomonas aeruginosa tobramycin-enhanced biofilm formation.

Authors:  Ali Tahrioui; Rachel Duchesne; Emeline Bouffartigues; Sophie Rodrigues; Olivier Maillot; Damien Tortuel; Julie Hardouin; Laure Taupin; Marie-Christine Groleau; Alain Dufour; Eric Déziel; Gerald Brenner-Weiss; Marc Feuilloley; Nicole Orange; Olivier Lesouhaitier; Pierre Cornelis; Sylvie Chevalier
Journal:  NPJ Biofilms Microbiomes       Date:  2019-05-23       Impact factor: 7.290

8.  Virulence Characteristics and an Action Mode of Antibiotic Resistance in Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Wontae Hwang; Sang Sun Yoon
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

9.  Selective Proteomic Analysis of Antibiotic-Tolerant Cellular Subpopulations in Pseudomonas aeruginosa Biofilms.

Authors:  Brett M Babin; Lydia Atangcho; Mark B van Eldijk; Michael J Sweredoski; Annie Moradian; Sonja Hess; Tim Tolker-Nielsen; Dianne K Newman; David A Tirrell
Journal:  MBio       Date:  2017-10-24       Impact factor: 7.867

10.  Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles.

Authors:  Katja Koeppen; Roxanna Barnaby; Angelyca A Jackson; Scott A Gerber; Deborah A Hogan; Bruce A Stanton
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.